| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00154210 |
| P698 | PubMed publication ID | 2187005 |
| P2093 | author name string | M Weller | |
| P Wiedemann | |||
| K Heimann | |||
| P2860 | cites work | New perspectives in cell adhesion: RGD and integrins | Q28280381 |
| Integrins: a family of cell surface receptors | Q28288125 | ||
| The Role of Breakdown of the Blood-Retinal Barrier in Cell-Injection Models of Proliferative Vitreoretinopathy | Q30462822 | ||
| Secretory products of macrophages | Q34557411 | ||
| Macrophages and microglia in the nervous system | Q34660547 | ||
| Ultrastructure of Bruch's membrane after krypton laser photocoagulation. II. Repair of Bruch's membrane and the role of macrophages | Q35055524 | ||
| Control of experimental massive periretinal proliferation by daunomycin: dose-response relation | Q71067804 | ||
| Temporary use of silicone oil in the treatment of proliferative vitreoretinopathy. An experimental study with a new animal model | Q71101215 | ||
| Intravitreal autotransplantation of fibroblasts | Q71138396 | ||
| Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil | Q71184897 | ||
| Surgical removal of vitreous. Its effect on intraocular fibroblast proliferation in the rabbit | Q71289941 | ||
| Unexpected traction retinal detachment: a complication of an animal model of pars plana vitrectomy | Q71298079 | ||
| The myofibroblast: biologic, pathologic, and theoretical considerations | Q71412184 | ||
| Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide | Q71424975 | ||
| Postoperative retinal fibrosis--a controlled clinical study of systemic steroid therapy | Q71477310 | ||
| Glucocorticosteroid inhibition of intraocular proliferation after injury | Q71500263 | ||
| Vitrectomy in penetrating eye injury. Results of a controlled trial of vitrectomy in an experimental posterior penetrating eye injury in the rhesus monkey | Q71504158 | ||
| Intraocular injection of silicone oil for experimental proliferative vitreoretinopathy | Q71722790 | ||
| Experimental tractional retinal detachment in rabbits. Clinical picture and histopathologic features | Q72442923 | ||
| Effects of Beta-Aminopropionitrile After Posterior Penetrating Injury in the Rabbit | Q72543016 | ||
| Inhibition of Intraocular Proliferations with Intravitreal Corticosteriods | Q72604206 | ||
| Experimental Intraocular Proliferation and Neovascularization | Q72680558 | ||
| Fluorouracil for the Treatment of Massive Periretinal Proliferation | Q72680562 | ||
| Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy | Q72731604 | ||
| TIME RELATIONSHIP BETWEEN ADMINISTRATION OF CORTISONE AND WOUND HEALING IN RATS | Q76853735 | ||
| Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration | Q93605481 | ||
| The effects of injections of cultured fibroblasts into the rabbit vitreous | Q93647549 | ||
| Experimental scar membranes in the rabbit's vitreous. An autoradiographic and quantitative morphological study | Q93654811 | ||
| Vitreous stimulates proliferation of fibroblasts and retinal pigment epithelial cells | Q93683492 | ||
| Vitreous membranes. Induction in rabbits by intravitreous leukocyte injections | Q70511631 | ||
| Serum contains chemoattractants for human retinal pigment epithelial cells | Q70701795 | ||
| Simulation of Massive Periretinal Proliferation by Autotransplantation of Retinal Pigment Epithelial Cells in Rabbits | Q70782652 | ||
| Proliferative vitreoretinopathy: the rabbit cell injection model for screening of antiproliferative drugs | Q70785893 | ||
| Characterization of avascular corneal wound healing fibroblasts. New insights into the myofibroblast | Q35855927 | ||
| Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate | Q36202521 | ||
| Platelet-derived growth factor in chemotactic for fibroblasts | Q36205866 | ||
| Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells | Q36214722 | ||
| A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro | Q37438001 | ||
| Factors involved in the control of fibroblast proliferation by glucocorticoids: a review | Q38165923 | ||
| Macrophages, wound repair and angiogenesis. | Q38189028 | ||
| Immunochemical analysis of periretinal membranes. Review and outlook. | Q38696365 | ||
| Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture. | Q39541332 | ||
| Method of Production and Natural History of Experimental Posterior Penetrating eye Injury in the Rhesus Monkey | Q39681074 | ||
| Histology of Wound, Vitreous, and Retina in Experimental Posterior Penetrating Eye Injury in the Rhesus Monkey | Q39681080 | ||
| The platelet-derived growth factor | Q39739322 | ||
| Macrophage procoagulant factors--mediators of inflammatory and neoplastic tissue lesions. | Q39749468 | ||
| Glucocorticoid action on connective tissue: from molecular mechanisms to clinical practice | Q39755232 | ||
| Growth factors and determinants of wound repair | Q39758937 | ||
| Experimental Immunogenic Proliferative Retinopathy in Monkeys | Q39817018 | ||
| Fibroblast chemotaxis | Q39829706 | ||
| Autotransplantation of retinal pigment epithelium in intravitreal diffusion chamber | Q41070959 | ||
| Posterior vitreous separation and retinal detachment induced by macrophages | Q41463322 | ||
| Experimental double-perforating injury of the posterior segment in rabbit eyes: the natural history of intraocular proliferation | Q41479349 | ||
| Structural basis of contraction in vitreal fibrous membranes | Q41818546 | ||
| Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts | Q41955517 | ||
| Drug treatment of proliferative vitreoretinopathy | Q42028767 | ||
| The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum | Q42588117 | ||
| Experimental model of proliferative vitreoretinopathy (PVR) in the vitrectomised eye: effect of silicone oil | Q42611582 | ||
| Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study | Q42613660 | ||
| Characterization of membranes removed during open-sky vitrectomy. | Q42665953 | ||
| Proliferation and metaplasia of intravitreal retinal pigment epithelium cell autotransplants | Q43443092 | ||
| Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix | Q43755354 | ||
| Demonstration of mononuclear phagocytes in a human epiretinal membrane using a monoclonal anti-human macrophage antibody | Q44022390 | ||
| Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy | Q44098797 | ||
| Transferrin and transferrin receptor expression in intraocular proliferative disease. APAAP-immunolabeling of retinal membranes and ELISA for vitreal transferrin | Q44274105 | ||
| Experimental Fibroplasia in the rabbit vitreous. Retinal detachment induced by autologous fibroblasts | Q44578751 | ||
| Vitreous macrophage elicitation: generation of stimulants for pigment epithelium in vitro | Q45042396 | ||
| Macrophage modulation of retinal pigment epithelial cell migration and proliferation | Q46080681 | ||
| Glial epiretinal membranes and contraction. Immunohistochemical and morphological studies | Q46103185 | ||
| Origin of simple glial epiretinal membranes in an animal model | Q46133835 | ||
| Effect of adriamycin on experimental proliferative vitreoretinopathy in the rabbit | Q49324308 | ||
| [Mononuclear phagocytes and their growth factors: pacemakers of proliferative vitreoretinopathy?] | Q50703992 | ||
| Early vitreous changes in experimental proliferative vitreoretinopathy. | Q52495048 | ||
| Platelet-induced vitreous membrane formation. | Q54382611 | ||
| Effect of the vitreous on retinal wound-healing | Q56990376 | ||
| Experimental Epiretinal Proliferation Induced by Intravitreal Red Blood Cells | Q56990381 | ||
| Transforming growth factor-beta: biological function and chemical structure | Q61688125 | ||
| Stimulation of human vascular endothelial cell growth by a platelet-derived growth factor and thrombin | Q67001729 | ||
| Inhibition of intraocular proliferation by homoharringtonine. An experimental study | Q67929741 | ||
| A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin | Q67939585 | ||
| Cytotoxic effects of daunomycin on retinal pigment epithelium in vitro | Q68171486 | ||
| Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach ot the fibrotic disorders | Q68254316 | ||
| The significance of fibronectin in vitreoretinal pathology. A critical evaluation | Q68466747 | ||
| Implantation of fibroblasts into vitrectomized eyes. Dose-response relationship and the putative inhibitory effect of sodium hyaluronate | Q68675428 | ||
| Chemotaxis of rat retinal glia to growth factors found in repairing wounds | Q68822934 | ||
| The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy | Q68936245 | ||
| Experimental intravitreal proliferation and neovascularization in the cynomolgus monkey | Q68952523 | ||
| [Structural proteins in proliferative vitreoretinopathy] | Q68980880 | ||
| Modulation of the effects of alveolar macrophages on lung fibroblast collagen production rate | Q68982325 | ||
| Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta | Q69004035 | ||
| Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy | Q69039368 | ||
| The development of vitreous membranes and retinal detachment induced by intravitreal carbon microparticles | Q69046788 | ||
| Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy | Q69106850 | ||
| Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment | Q69398227 | ||
| Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye | Q69398244 | ||
| Pharmacological therapy for proliferative vitreoretinopathy | Q69515115 | ||
| Inhibition of retinal pigment epithelial cell attachment by a synthetic peptide derived from the cell-binding domain of fibronectin | Q69585665 | ||
| Low-dose colchicine inhibits astrocyte, fibroblast, and retinal pigment epithelial cell migration and proliferation | Q69585668 | ||
| Oral colchicine for the treatment of experimental traction retinal detachment | Q69585671 | ||
| Human retinal pigment epithelial cells in the vitreous of the owl monkey | Q69690488 | ||
| Experimental study on drug therapy of "traction retinal detachment" after posterior penetrating eye injury in the rabbit | Q69691573 | ||
| Development of traction retinal detachments following intravitreal injections of retinal Muller and pigment epithelial cells | Q69691592 | ||
| The pathophysiology of proliferative vitreoretinopathy | Q69847750 | ||
| Retinal wound healing. Cellular activity at the vitreoretinal interface | Q70011862 | ||
| Fibronectin | Q70023013 | ||
| Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment | Q70025955 | ||
| A retinal pigment epithelial cell-derived growth factor(s) | Q70025958 | ||
| Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells | Q70083229 | ||
| Retinal pigment epithelial cells release a chemoattractant for astrocytes | Q70104063 | ||
| Induction of DNA synthesis by co-culture of retinal glia and pigment epithelium | Q70110886 | ||
| Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo | Q70110899 | ||
| Epiretinal and vitreous membranes. Comparative study of 56 cases | Q70165534 | ||
| [Role of macrophages and fibronectin in vitreoretinal proliferation] | Q70211347 | ||
| Proteins of the extracellular matrix in vitreoretinal membranes | Q70214667 | ||
| Experimental Epiretinal Membranes Induced by Intravitreal Carbon Particles | Q70279608 | ||
| A comparison of different cellular inocula in an experimental model of massive periretinal proliferation | Q70362693 | ||
| The role of cellular proliferation in an experimental model of massive periretinal proliferation | Q70362698 | ||
| Epiretinal membrane formation after vitrectomy | Q70388996 | ||
| Effects of cytotoxic drugs on proliferative vitreoretinopathy in the rabbit cell injection model | Q70474838 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | wound healing | Q1509074 |
| P304 | page(s) | 105-117 | |
| P577 | publication date | 1990-03-01 | |
| P1433 | published in | International Ophthalmology | Q15763839 |
| P1476 | title | Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place? | |
| P478 | volume | 14 |
| Q43653227 | Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial |
| Q73544419 | Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR) |
| Q70587960 | Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages |
| Q90607435 | Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment |
| Q72026554 | Distribution of Growth Factors in Subfoveal Neovascular Membranes in Age-related Macular Degeneration and Presumed Ocular Histoplasmosis Syndrome |
| Q89696137 | Elevated M2 Macrophage Markers in Epiretinal Membranes With Ectopic Inner Foveal Layers |
| Q44405556 | Elevated proto-oncogene and collagen mRNA expression in PVR retinas |
| Q34427717 | Enhanced PKCδ and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF. |
| Q47356910 | Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy |
| Q47401527 | Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes. |
| Q71976831 | Immunohistochemistry of anterior proliferative vitreoretinopathy. Report of 11 cases |
| Q72510534 | Increased lipid peroxide level and myeloperoxidase activity in the vitreous of patients suffering from proliferative vitreoretinopathy |
| Q40617968 | Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells |
| Q37470227 | Involvement of Müller glial cells in epiretinal membrane formation |
| Q45006548 | Neuropeptide Y-evoked proliferation of retinal glial (Muller) cells |
| Q73198807 | Non-vascular vitreoretinopathy: the cells and the cellular basis of contraction |
| Q39693709 | Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy |
| Q56657337 | Pars plana vitrectomy combined with scleral buckle versus pars plana vitrectomy for giant retinal tear |
| Q46630762 | Phosphorylation of extracellular signal-regulated kinase and p27(KIP1) after retinal detachment |
| Q41860282 | Plasminogen in proliferative vitreoretinal disorders |
| Q39690558 | Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction |
| Q37250122 | Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid |
| Q77144020 | Proliferative vitreoretinopathy: an overview |
| Q34572836 | Proliferative vitreoretinopathy: risk factors and pathobiology |
| Q37009808 | Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis |
| Q43876241 | Proteomics of post-traumatic proliferative vitreoretinopathy in rabbit retina reveals alterations to a variety of functional proteins |
| Q39281358 | Retinal Pigment Epithelium and Müller Progenitor Cell Interaction Increase Müller Progenitor Cell Expression of PDGFRα and Ability to Induce Proliferative Vitreoretinopathy in a Rabbit Model |
| Q73816561 | Retinal pigment epithelial cells: autocrine and paracrine stimulation of extracellular matrix contraction |
| Q36683585 | SU9518 inhibits proliferative vitreoretinopathy in fibroblast and genetically modified Müller cell-induced rabbit models |
| Q43083277 | Safety and feasibility of a novel intravitreal tamponade using a silicone oil/acetyl-salicylic acid suspension for proliferative vitreoretinopathy: first results of the Austrian Clinical Multicenter Study |
| Q43653223 | Shaken not stirred |
| Q28086797 | Steroids as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery: a systematic review and meta-analysis |
| Q35862233 | Strategies to influence PVR development |
| Q73251170 | Surgical management of traumatic retinal detachment with perfluorocarbon liquid. The Vitreon Study Group |
| Q41085758 | The impact of octreotide in experimental proliferative vitreoretinopathy |
| Q40869093 | Traction retinal detachment. XLIX Edward Jackson Memorial Lecture |
| Q90707319 | Upregulated CD200 in pre-retinal proliferative fibrovascular membranes of proliferative diabetic retinopathy patients and its correlation with vascular endothelial growth factor |
| Q35359052 | Use of systemic steroid after successful macular surgery in eyes with epiretinal membrane: a randomized, controlled clinical study |
| Q38293676 | Vitreous humor in the pathologic scope: insights from proteomic approaches. |
Search more.